Search - tctmd.com

Displaying 621 - 640 of 1229

Sort: Relevancy | Date

Presentation TVT 2016

TAVR in Mitral Valve Case Presentation (VIV): Focus on Imaging

Presenter: Douglas C Shook

June 16, 2016

Presentation TVT 2016

TVT 1126: On-Pump Beating-Heart Direct Transatrial Implantation of Edwards Sapien 3 Valve for Mitral Stenosis With Severely Calcified Annulus

Presenter: Mohammad Sarraf, MD

June 16, 2016

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

Presentation TVT 2016

TVT 1035: Transapical Implantation of Mechanically Expanding Lotus Valve in a Native Severe Calcific Mitral Valve Stenosis

Presenter: Renzo Pessotto

June 16, 2016

Presentation TVT 2016

TAVR in Mitral Valve Bioprothesis (VIV): Anatomical Considerations

Presenter: Danny Dvir

June 16, 2016

Presentation TVT 2016

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

Presenter: Yoshifumi Nakajima, MD

June 16, 2016

Presentation TVT 2016

TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting

Presenter: Vikas Aggarwal, MD

June 16, 2016

Presentation TVT 2016

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

Presenter: Creighton W. Don

June 16, 2016

Presentation TVT 2016

TAVR Bioskills

Presenter: Mark Reisman

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

Yael L. Maxwell

June 15, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

Presentation SOLACI 2016

Complex Cases in TAVI: Our Experience With the Last Generation Valves

Presenter: Vin?cius Esteves

June 09, 2016

News Daily News

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

Michael O'Riordan

June 07, 2016

News Daily News

La Evolución de la TAVR en Dinamarca podría Tener Imlpicacines en Otros Países

L.A. McKeown

June 06, 2016

News Daily News

Evolution of TAVR in Denmark May Have Implications for Other Countries

L.A. McKeown

June 06, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

Advertisement

TAVR in Mitral Valve Case Presentation (VIV): Focus on Imaging

TVT 1126: On-Pump Beating-Heart Direct Transatrial Implantation of Edwards Sapien 3 Valve for Mitral Stenosis With Severely Calcified Annulus

The Case for and Against Cerebral Embolic Protection During TAVR

TVT 1035: Transapical Implantation of Mechanically Expanding Lotus Valve in a Native Severe Calcific Mitral Valve Stenosis

TAVR in Mitral Valve Bioprothesis (VIV): Anatomical Considerations

TVT 1063: What Is the Optimal Treatment for Residual Commissural Jet Following MitraClip? Ventricular Septal Defect Occluder Device vs Gore CARDIOFORM

TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting

TVT 1123: TAVR Valve Used to Treat Native Mitral Regurgitation A Hybrid Surgical Transcatheter Approach

TAVR Bioskills

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

La Alta Mortalidad que Sobreviene tras una Endocarditis Infecciosa Post-TAVR Justifica Mejores Medidas de Prevención y Tratamiento

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Complex Cases in TAVI: Our Experience With the Last Generation Valves

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

La Evolución de la TAVR en Dinamarca podría Tener Imlpicacines en Otros Países

Evolution of TAVR in Denmark May Have Implications for Other Countries

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content